|
C5ORF25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.424150E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.632850E-01 |
| Normal-vs-Stage2 |
3.464300E-02 |
| Normal-vs-Stage3 |
2.583900E-03 |
| Normal-vs-Stage4 |
9.543900E-02 |
| Stage1-vs-Stage2 |
1.459990E-01 |
| Stage1-vs-Stage3 |
2.924800E-03 |
| Stage1-vs-Stage4 |
1.237150E-01 |
| Stage2-vs-Stage3 |
3.578000E-01 |
| Stage2-vs-Stage4 |
2.163200E-01 |
| Stage3-vs-Stage4 |
3.311600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.937800E-03 |
| Normal-vs-AfricanAmerican |
6.728200E-02 |
| Normal-vs-Asian |
1.036240E-01 |
| Caucasian-vs-AfricanAmerican |
5.605000E-01 |
| Caucasian-vs-Asian |
5.625400E-01 |
| AfricanAmerican-vs-Asian |
3.116200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.547900E-02 |
| Normal-vs-Female |
2.34289999999637E-05 |
| Male-vs-Female |
2.597000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.702400E-02 |
| Normal-vs-Extreme_Weight |
3.346200E-02 |
| Normal-vs-Obese |
1.232020E-02 |
| Normal-vs-Extreme_Obese |
8.715800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.156200E-01 |
| Normal_Weight-vs-Obese |
6.095800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.198280E-02 |
| Extreme_Weight-vs-Obese |
6.280000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.222800E-03 |
| Obese-vs-Extreme_Obese |
4.195400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.200020E-02 |
| Normal-vs-Age(41-60Yrs) |
2.420000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.755600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.713400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.349400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.621100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.914560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.241200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.050000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.493900E-02 |
| Normal-VS-Type2 PRCC |
1.189240E-01 |
| Normal-VS-KIRP CIMP |
1.77994999999154E-05 |
| Normal-VS-Unclassified PRCC |
9.129600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.261800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.91040000380372E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
5.024200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.48219999999799E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.785600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.222600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.971000E-01 |
| Normal-vs-N1 |
5.815600E-03 |
| Normal-vs-N2 |
1.204440E-01 |
| N0-vs-N1 |
1.351960E-02 |
| N0-vs-N2 |
3.154100E-02 |
| N1-vs-N2 |
8.270400E-01 |
|
|
